Antibiotics Simplified

Description

“This book focuses on key points of basic microbiology and antimicrobial pharmacotherapy and organizes them into a concise guide … must-have antimicrobial reference guide for all medical and pharmacy students.” - Lindsay McDonnell, PharmD for Doody’s Review Service Antibiotics Simplified, Fifth Edition is a best-selling, succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also contains concise Drug Class Reviews with an explanation of the characteristics of various classes of antibacterial drugs and antifungal drugs. This text simplifies learning infectious disease pharmacotherapy and condenses the many facts that are taught about antibiotics into one quick reference guide. This guide will help students learn the characteristics of antibiotics and why an antibiotic is useful for an indication. With an understanding of the characteristics of the antibiotics, students will be able to make a logical choice to treat an infection more easily. Title Page Copyright Page Contents Acknowledgments Introduction New to the Fifth Edition Chapter 1: The Wonderful World of Microbiology Chapter 2: General Approach to Infectious Diseases Chapter 3: Antibiotic Pharmacokinetics Chapter 4: Antibiotic Pharmacodynamics Chapter 5: Adverse Consequences of Antibiotic Use Chapter 6: Antibiotic Resistance Chapter 7: Beta-Lactams Penicillins Natural Penicillins Antistaphylococcal Penicillins Aminopenicillins Penicillin/Beta-lactamase Inhibitor Combinations Cephalosporins First-generation Cephalosporins Second-generation Cephalosporins Third-generation Cephalosporins Fourth-generation Cephalosporins Anti-MRSA Cephalosporins Siderophore Cephalosporin Cephalosporin/Beta-lactamase Inhibitor Combinations Carbapenems Carbapenem/Beta-lactamase Inhibitor Combinations Monobactams Chapter 8: Glycopeptides and Short-Acting Lipoglycopeptides Chapter 9: Long-Acting Glycopeptides Chapter 10: Fluoroquinolones Chapter 11: Aminoglycosides Chapter 12: Tetracyclines and Modified Tetracyclines Chapter 13: Macrolides Chapter 14: Oxazolidinones Chapter 15: Nitroimidazoles Chapter 16: Nitrofurans and Fosfomycin Chapter 17: Streptogramins Chapter 18: Cyclic Lipopeptides Chapter 19: Folate Antagonists Chapter 20: Lincosamides Chapter 21: Polymyxins Chapter 22: Clostridioides difficile-Specific Agents Chapter 23: Antimycobacterial Drugs Chapter 24: Rifamycins Chapter 25: Isoniazid Chapter 26: Pyrazinamide Chapter 27: Ethambutol Chapter 28: Antifungal Drugs Chapter 29: Polyenes Chapter 30: Antifungal Antimetabolite Chapter 31: Azoles Fluconazole Itraconazole Voriconazole Posaconazole Isavuconazole Chapter 32: Echinocandins Chapter 33: Terpenoids Chapter 34: Antiviral Drugs Chapter 35: Anti-Herpes Simplex Virus and Varicella-Zoster Virus Agents Chapter 36: Anti-cytomegalovirus Agents Chapter 37: Anti-influenza Antivirals Chapter 38: Anti-coronavirus Antivirals Chapter 39: Antiretroviral Drugs Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Non-nucleoside Reverse Transcriptase Inhibitors Protease Inhibitors Integrase Inhibitors Entry, Attachment, and Fusion Inhibitors Chapter 40: Antiviral Interferons Chapter 41: Direct-Acting Anti-hepatitis C Agents Chapter 42: Ribavirin Chapter 43: Hepatitis B Nucleoside Analogs Chapter 44: Anti-SARS-CoV-2 Antibody Therapies Chapter 45: Antiparasitic Drugs Chapter 46: Quinolines Chapter 47: Atovaquone Chapter 48: Benzimidazoles Chapter 49: Pentamidine Chapter 50: Ivermectin Chapter 51: Artemisinins Appendix 1: Selected Normal Human Flora Appendix 2: Spectrum of Activity Appendix 3: Empiric Regimens for Common Infections Index